Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats

Acta Pharmacologica Sinica

Volumn 27, Issue 9, 2006, Pages 1103-1110

  Zhou, Yu ^a   Fang, San Hua ^a   Ye, Yi Lu ^a   Chu, Li Sheng ^a   Zhang, Wei Ping ^a   Wang, Meng Ling ^a   Wei, Er Qing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

5 lipoxygenase; Astrocyte; Caffeic acid; Focal cerebral ischemia; Leukotriene; Neuron

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CAFFEIC ACID; LEUKOTRIENE B4; PEPTIDOLEUKOTRIENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN ATROPHY; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN LEVEL; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FATTY ACID SYNTHESIS; HEMISPHERE; MALE; MEASUREMENT; METABOLITE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OBSERVATION; RAT; RAT STRAIN; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; BRAIN; CAFFEIC ACIDS; CYSTEINE; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; LEUKOTRIENE B4; LEUKOTRIENES; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33748802214     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00406.x     Document Type: Article

References (36)

1. Czok G. Coffee and health. Z Ernahrungswiss 1977; 16: 248-55.
2. Cui CB, Tezuka Y, Kikuchi T, Nakano H, Tamaoki T, Park JH. Constituents of a fern, Davallia mariesii Moore. I. Isolation and structures of davallialactone and a new flavanone glucuronide. Chem Pharm Bull (Tokyo) 1990; 38: 3218-25.
3. Sondheimer E. On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch Biochem Biophys 1958; 74: 131-8.
4. Vieira O, Laranjinha J, Madeira V, Almeida L. Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Biochem Pharmacol 1998; 55: 333-40.
5. Bors W, Michel C, Stettmaier K, Lu Y, Foo LY. Antioxidant mechanisms of polyphenolic caffeic acid oligomers, constituents of Salvia officinalis. Biol Res 2004; 37: 301-11.
6. da Cunha FM, Duma D, Assreuy J, Buzzi FC, Niero R, Campos MM, et al. Caffeic acid derivatives: in vitro and in vivo anti-inflammatory properties. Free Radic Res 2004; 38: 1241-53.
7. Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, et al. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 2003; 21: 283-9.
8. Tsai SK, Lin MJ, Liao PH, Yang CY, Lin SM, Liu SM, et al. Caffeic acid phenethyl ester ameliorates cerebral infarction in rats subjected to focal cerebral ischemia. Life Sci 2006; 78: 2758-62.
9. Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta 1984; 792: 92-7.
10. Maccarrone M, Battista N, Meloni M, Bari M, Galleri G, Pippia P, et al. Creating conditions similar to those that occur during exposure of cells to microgravity induces apoptosis in human lymphocytes by 5-lipoxygenase-mediated mitochondrial uncoupling and cytochrome c release. J Leukoc Biol 2003; 73: 472-81.
11. Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 2004; 15: 2181-4.
12. Ge QF, Wei EQ, Zhang WP, Hu X, Huang XJ, Zhang L, et al. Activation of 5-lipoxygenase after ischemic injury is partly mediated via NMDA receptor in rat cortical neurons. J Neurochem 2006; 97: 992-1004.
13. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248-54.
14. Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 2004; 35: 2220-5.
15. Fawcett JW, Asher RA. The glial scar and central nervous sys tem repair. Brain Res Bull 1999; 49: 377-91.
16. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-56.
17. Persson L, Hardemark HG, Bolander HG, Hillered L, Olsson Y. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 1989; 20: 641-5.
18. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003; 98: 465-73.
19. Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002; 23: 871-7.
20. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
21. Prestigiacomo CJ, Kim SC, Connolly ES Jr, Liao H, Yan SF, Pinsky DJ. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke 1999; 30: 1110-7.
22. Uz T, Pesold C, Longone P, Manev H. Aging-associated upregulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J 1998; 12: 439-49.
23. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-6.
24. Yu GL, Wei EQ, Wang ML, Zhang WP, Zhang SH, Weng JQ, et al. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res 2005; 1053: 116-25.
25. Yonemori F, Yamaguchi T, Yamada H, Tamura A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18: 1099-106.
26. Ciccarelli R, D'Alimonte I, Santavenere C, D'Auro M, Ballerini P, Nargi E, et al. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 2004; 20: 1514-24.
27. Wei X, Zhao L, Ma Z, Holtzman DM, Yan C, Dodel RC, et al. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 2004; 127: 2629-35.
28. Moskowitz MA, Kiwak KJ, Hekimian K, Levine L. Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science 1984; 224: 886-9.
29. Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol 2001; 133: 1323-9.
30. Rao AM, Hatcher JF, Kindy MS, Dempsey RJ. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res 1999; 24: 1225-32.
31. Namura Y, Shio H, Kimura J. LTC4/LTB4 alterations in rat forebrain ischemia and reperfusion and effects of AA-861, CV-3988. Acta Neurochir Suppl (Wien) 1994; 60: 296-9.
32. Ilhan A, Akyol O, Gurel A, Armutcu F, Iraz M, Oztas E. Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. Free Radic Biol Med 2004; 37: 386-94.
33. Hayashi N, Miyata S, Kariya Y, Takano R, Hara S, Kamei K. Attenuation of glial scar formation in the injured rat brain by heparin oligosaccharides. Neurosci Res 2004; 49: 19-27.
34. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci USA 2004; 101: 8786-90.
35. 2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 2003; 43: 190-4.
36. Riva MA, Molteni R, Racagni G. Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol. Brain Res Mol Brain Res 1998; 57: 38-45.